Related Experiment Video
Updated: Mar 20, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Immune Checkpoint Inhibitor-Induced Myocarditis: A Late Presentation
Adrienne Koos1, Farnoosh Shariati2, Senthil Anand2
1Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, LA.
Immune checkpoint inhibitors (ICIs) can cause myocarditis, a serious heart condition. Early recognition and treatment of ICI-associated myocarditis are crucial for patient survival, even with delayed symptoms.
Area of Science:
- Oncology
- Cardiology
- Immunology
Background:
- Immune checkpoint inhibitors (ICIs) have transformed cancer treatment, offering new options for various malignancies.
- Despite their efficacy, ICIs can induce immune-related adverse events, including myocarditis.
- ICI-associated myocarditis presents with diverse cardiac symptoms and is histopathologically confirmed by myocardial inflammation.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Pericarditis III: Medical Management

